HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Krista A Power Selected Research

Estrogen Receptor Modulators (Antiestrogen)

10/2003Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Krista A Power Research Topics

Disease

14Inflammation (Inflammations)
11/2021 - 05/2014
14Breast Neoplasms (Breast Cancer)
01/2021 - 10/2003
11Neoplasms (Cancer)
01/2021 - 03/2006
8Colitis
11/2018 - 05/2014
5Obesity
11/2021 - 10/2014
4Body Weight (Weight, Body)
02/2021 - 03/2006
1Carcinogenesis
01/2021
1Insulin Resistance
10/2019
1Herpes Zoster
08/2019
1Infections
11/2018
1Wounds and Injuries (Trauma)
01/2018
1Overnutrition
11/2017
1Dysbiosis
11/2016

Drug/Important Bio-Agent (IBA)

8LignansIBA
06/2014 - 03/2006
7Dextrans (Dextran)FDA Link
09/2018 - 05/2014
7Estrogens (Estrogen)FDA Link
08/2009 - 07/2006
6Messenger RNA (mRNA)IBA
01/2021 - 01/2015
6sodium sulfate (sodium bisulfate)FDA LinkGeneric
09/2018 - 06/2014
5Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2021 - 06/2014
5Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2003
5Drinking WaterIBA
09/2018 - 05/2014
4AdipokinesIBA
10/2019 - 10/2014
4Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2008
4Phytoestrogens (Phytoestrogen)IBA
08/2009 - 03/2006
4IsoflavonesIBA
08/2009 - 03/2006
4GenisteinIBA
08/2009 - 03/2006
42,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA
08/2009 - 03/2006
4TamoxifenFDA LinkGeneric
01/2008 - 01/2007
3LeptinIBA
02/2021 - 10/2019
3AdiponectinIBA
01/2021 - 01/2016
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2016 - 06/2014
3Estrogen Receptor alphaIBA
11/2008 - 10/2003
3Estrogen ReceptorsIBA
11/2008 - 10/2003
3Soybean Proteins (Soy Protein)IBA
11/2008 - 07/2007
32,3-bis(3'-hydroxybenzyl)butane-1,4-diol (enterodiol)IBA
07/2007 - 03/2006
2InterferonsIBA
11/2021 - 07/2015
2ResistinIBA
02/2021 - 01/2021
2Hormones (Hormone)IBA
02/2021 - 01/2021
2Fish OilsIBA
01/2021 - 01/2016
2Volatile Fatty AcidsIBA
08/2019 - 11/2018
2Immunoglobulin A (IgA)IBA
09/2018 - 01/2018
2CarbohydratesIBA
09/2018 - 01/2018
2Peroxidase (Myeloperoxidase)IBA
11/2016 - 06/2014
2CytokinesIBA
02/2016 - 06/2014
2Interleukin-6 (Interleukin 6)IBA
07/2015 - 01/2015
2SodiumIBA
07/2015 - 05/2014
2Estrogen Receptor betaIBA
11/2008 - 10/2003
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2008 - 09/2007
2Estradiol (Delestrogen)FDA LinkGeneric
09/2007 - 03/2006
1Epidermal Growth Factor (EGF)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2019
1Cadherins (E-Cadherin)IBA
08/2019
1Claudin-2IBA
08/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2019
1Guanosine Triphosphate (GTP)IBA
01/2018
1Interleukin-22 (IL-22)IBA
01/2018
1Interleukin-27 (Interleukin 27)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1GlycosidesIBA
11/2016
1Rutin (Rutoside)IBA
11/2016
1FlavonoidsIBA
11/2016
1InflammasomesIBA
01/2016
1Interleukin-17 (Interleukin 17)IBA
07/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2015
1InterleukinsIBA
07/2015
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2015
1Trefoil Factor-3IBA
07/2015
1Toll-Like Receptor 4IBA
07/2015
1Interleukin-18 (Interleukin 18)IBA
01/2015
1LipidsIBA
01/2015
1antineoplaston A10 (A 10)IBA
06/2014
1Cyclin D1IBA
11/2008
1Tumor Biomarkers (Tumor Markers)IBA
11/2008
1TritiumIBA
01/2008
1secoisolariciresinol diglucosideIBA
01/2008
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2007
1Indicators and Reagents (Reagents)IBA
10/2003
1Estrogen Receptor Modulators (Antiestrogen)IBA
10/2003
1LigandsIBA
10/2003

Therapy/Procedure

2Subcutaneous Injections
07/2006 - 03/2006
1Oral Administration
01/2008